KF
KYNB icon

Krilogy Financial’s Kyntra Bio KYNB Stock Holding History

Krilogy Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8
Closed -$9K – 317
2018
Q1 		$9K Buy
8
+4
+100% +$5.27K ﹤0.01% 539
2017
Q4 		$5K Hold
4
– – ﹤0.01% 595
2017
Q3 		$5K Sell
4
-4
-50% -$4.21K ﹤0.01% 648
2017
Q2 		$6K Hold
8
– – ﹤0.01% 577
2017
Q1 		$4K Hold
8
– – ﹤0.01% 592
2016
Q4 		$4K Hold
8
– – ﹤0.01% 592
2016
Q3 		$4K Hold
8
– – ﹤0.01% 613
2016
Q2 		$3K Buy
+8
New +$3.66K ﹤0.01% 651

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Krilogy Financial's KYNB Position: Q2 2018 in Review

Krilogy Financial sold out of Kyntra Bio (KYNB) in Q2 2018, closing a stake of 8 shares — an estimated $9K sold.

Krilogy Financial first reported a position in KYNB in Q2 2016 and held it in 8 quarters. The position peaked at $9K in Q1 2018. 192 funds tracked by Wall St. Rank hold KYNB as of Q2 2018.

  • Krilogy Financial reported no remaining Kyntra Bio position as of Q2 2018 after selling out during the quarter.
  • Krilogy Financial sold 8 Kyntra Bio shares in Q2 2018, an estimated $9K.
  • Krilogy Financial first reported a position in Kyntra Bio in Q2 2016 and held it in 8 quarters.
  • Krilogy Financial's Kyntra Bio position peaked at $9K in Q1 2018.
  • 192 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2018.

Based on Krilogy Financial's 13F filing for Q2 2018, filed 15 Aug 2018.